Patent ID: 11964057
Assignee: RJH BIOSCIENCES INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 15:
16. A method of treating, preventing, or ameliorating blood cancer in a subject, comprising administering to the subject an effective amount of a compound comprising a polymer and a lipid covalently linked via N-acylation, the polymer being polyethylenimine having a molecular weight ranging from 0.6 kDa to 2.0 kDa, and the lipid being cholesterol or a derivative thereof, or lauric acid or a derivative thereof, wherein the compound is capable of delivering a ribonucleic acid; a nanoparticle comprising the compound complexed to a ribonucleic acid, or a composition comprising the compound or the nanoparticle and a pharmaceutically acceptable carrier, a targeting ligand, an anti-fouling agent, or combination thereof.